SEARCH

SEARCH BY CITATION

References

  • 1
    De Stavola B. Statistical facts about cancers on which Doctor Rigoni-Stern based his contribution to the Surgeons' Subgroup of the IV Congress of the Italian Scientists on 23 September 1842 (translation). Stat Med 1987; 6: 8814.
  • 2
    IARC. Human papillomavirus. Monographs on the evaluation of carcinogenic risks to humans, vol. 64. Lyon: IARC Press, 1995.
  • 3
    Boyd JT, Doll R. A study of the aetiology of carcinoma of the cervix uteri. Br J Cancer 1964; 13: 41934.
  • 4
    Rotkin ID. Adolescent coitus and cervical cancer: associations of related events with increased risk. Cancer Res 1967; 27: 60317.
  • 5
    Wynder EL, Cornfield J, Schroff PD, Doraiswami KR. A study of environmental factors in carcinoma of the cervix. Am J Obstet Gynecol 1954; 68: 101647.
  • 6
    Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989; 130: 48696.
  • 7
    Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJLM, Bosch FX. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359: 1093101.
  • 8
    Skegg DC. Oral contraceptives, parity, and cervical cancer. Lancet 2002; 359: 108081.
  • 9
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 1536.
  • 10
    TavassoliF, DevileeP, eds. Pathology and genetics: tumours of the breast and genital organs. World Health Organization classification of tumours. Lyon: IARC Press, 2003.
  • 11
    Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 51827.
  • 12
    Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991; 10: 102535.
  • 13
    Plummer M. Improved estimates of floating absolute risk. Stat Med 2004; 23: 93104.
  • 14
    Boyce JG, Lu T, Nelson JH,Jr, Fruchter RG. Oral contraceptives and cervical carcinoma. Am J Obstet Gynecol 1977; 128: 7616.
  • 15
    Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study. Am J Epidemiol 1987; 126: 592604.
  • 16
    Ebeling K, Nischan P, Schindler C. Use of oral contraceptives and risk of invasive cervical cancer in previously screened women. Int J Cancer 1987; 39: 42730.
  • 17
    Hsieh CY, You SL, Kao CL, Chen CJ. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. Anticancer Res 1999; 19: 4495500.
  • 18
    Irwin KL, Rosero-Bixby L, Oberle MW, Lee NC, Whatley AS, Fortney JA, Bonhomme MG. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association? JAMA 1988; 259: 5964.
  • 19
    Lazcano-Ponce EC, Hernández-Avila M, Lopez-Carrillo L, Alonso de Ruiz P, Torres-Lobaton A, González-Lira G, Romieu I. [Reproductive risk factors and sexual history associated with cervical cancer in Mexico]. Rev Invest Clin 1995; 47: 37785.
  • 20
    Slattery ML, Robison LM, Schuman KL, French TK, Abbott TM, Overall JC,Jr, Gardner JW. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA 1989; 261: 15938.
  • 21
    Stone KM, Zaidi A, Rosero-Bixby L, Oberle MW, Reynolds G, Larsen S, Nahmias AJ, Lee FK, Schachter J, Guinan ME. Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology 1995; 6: 40914.
  • 22
    Stone KM. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis 1995; 20 ( Suppl 1): S917.
  • 23
    Talbott E, Norman S, Kuller L, Ishii E, Baffone K, Dunn M, Krampe B, Weinberg G. Refining preventive strategies for invasive cervical cancer: a population-based case-control study. J Women's Health 1995; 4: 38795.
  • 24
    Thomas DB. An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervix. Am J Epidemiol 1973; 98: 1028.
  • 25
    Shapiro S, Rosenberg L, Hoffman M, Kelly JP, Cooper DD, Carrara H, Denny LE, du Toit G, Allan BR, Stander IA, Williamson AL. Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Cancer Causes Control 2003; 14: 48595.
  • 26
    Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46000 women from Royal College of General Practitioners' oral contraception study. BMJ 1999; 318: 96100.
  • 27
    Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer–further findings from the Oxford Family Planning Association contraceptive study. Br J Cancer 1996; 73: 12917.
  • 28
    Gram IT, Austin H, Stalsberg H. Cigarette smoking and the incidence of cervical intraepithelial neoplasia, grade III, and cancer of the cervix uteri. Am J Epidemiol 1992; 135: 3416.
  • 29
    Ylitalo N, Sorensen P, Josefsson A, Frisch M, Sparen P, Ponten J, Gyllensten U, Melbye M, Adami HO. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999; 81: 35765.
  • 30
    Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000; 83: 156572.
  • 31
    Castle PE, Shields T, Kirnbauer R, Manos MM, Burk RD, Glass AG, Scott DR, Sherman ME, Schiffman M. Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity. Sex Transm Dis 2002; 29: 1827.
  • 32
    Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJLM. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002; 325: 572.
  • 33
    Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001; 84: 121926.
  • 34
    The Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population.. Breast Cancer Res 1999; 1: 7380.
  • 35
    Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst 1986; 77: 106377.
  • 36
    Brinton LA, Hamman RF, Huggins GR, Lehman HF, Levine RS, Mallin K, Fraumeni JF,Jr. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987; 79: 2330.
  • 37
    Kjaer SK, Dahl C, Engholm G, Bock JE, Lynge E, Jensen OM. Case-control study of risk factors for cervical neoplasia in Denmark. II. Role of sexual activity, reproductive factors, and venereal infections. Cancer Causes Control 1992; 3: 33948.
  • 38
    Cuzick J, Singer A, De Stavola BL, Chomet J. Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 1990; 26: 68490.
  • 39
    Green J, Berrington de González A, Sweetland S, Beral V, Chilvers C, Crossley B, Deacon J, Hermon C, Jha P, Mant D, Peto J, Pike M, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003; 89: 207886.
  • 40
    Ursin G, Pike MC, Preston-Martin S, d'Ablaing G,III, Peters RK. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States). Cancer Causes Control 1996; 7: 391401.
  • 41
    Bosch FX, Muñoz N, de Sanjosé S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC, Tafur L, Kaldor JM, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52: 75058.
  • 42
    Cuzick J, Sasieni P, Singer A. Risk factors for invasive cervix cancer in young women. Eur J Cancer 1996; 32A: 83641.
  • 43
    Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, Schwartz SM, Beckmann AM, Hagensee ME, Mandelson MT, Galloway DA. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996; 5: 5418.
  • 44
    Madeleine MM, Daling JR, Schwartz SM, Shera K, McKnight B, Carter JJ, Wipf GC, Critchlow CW, McDougall JK, Porter P, Galloway DA. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 2001; 10: 1717.
  • 45
    Altekruse SF, Lacey JV,Jr, Brinton LA, Gravitt PE, Silverberg SG, Barnes WA,Jr, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 2003; 188: 65763.
  • 46
    Silins I, Wang X, Tadesse A, Jansen KU, Schiller JT, Avall-Lundqvist E, Frankendal B, Dillner J. A population-based study of cervical carcinoma and HPV infection in Latvia. Gynecol Oncol 2004; 93: 48492.
  • 47
    WHO. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study.WHO Collaborative Study of Neoplasia and Steriod Contraceptives. Int J Cancer 1993; 55: 22836.
  • 48
    Parazzini F, La Vecchia C, Negri E, Cecchetti G, Fedele L. Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia. Br J Cancer 1989; 59: 8059.
  • 49
    Muñoz N, Bosch FX, de Sanjosé S, Vergara A, del Moral A, Muñoz MT, Tafur L, Gili M, Izarzugaza I, Viladiu P, Daniel RW, Alonso de Ruiz P, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2: 42331.
  • 50
    Rolón PA, Smith JS, Muñoz N, Klug SJ, Herrero R, Bosch X, Llamosas F, Meijer CJLM, Walboomers JM. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000; 85: 48691.
  • 51
    Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69: 11419.
  • 52
    Chichareon S, Herrero R, Muñoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJLM, Walboomers JM. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90: 5057.
  • 53
    Bayo S, Bosch FX, de Sanjosé S, Muñoz N, Combita AL, Coursaget P, Diaz M, Dolo A, van den Brule AJ, Meijer CJLM. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002; 31: 2029.
  • 54
    Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJLM, Walboomers JM. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998; 90: 439.
  • 55
    Chaouki N, Bosch FX, Muñoz N, Meijer CJLM, El Gueddari B, El Ghazi A, Deacon J, Castellsagué X, Walboomers JM. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998; 75: 54654.
  • 56
    Santos C, Muñoz N, Klug S, Almonte M, Guerrero I, Alvarez M, Velarde C, Galdos O, Castillo M, Walboomers J, Meijer CJLM, Caceres E. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001; 85: 96671.
  • 57
    Hammouda D, Muñoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, Djedeat B, Fontanière B, Snijders PJF, Meijer CJLM, Franceschi S. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005; 113: 48389.
  • 58
    Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJF, Muñoz N, Meijer CJLM, Herrero R. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003; 107: 12733.
  • 59
    Thomas DB, Ray RM. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1996; 144: 2819.
  • 60
    Thomas DB, Qin Q, Kuypers J, Kiviat N, Ashley RL, Koetsawang A, Ray RM, Koetsawang S. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol 2001; 153: 7329.
  • 61
    Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D, Connor M, Bull D, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000; 88: 48992.
  • 62
    Smith JS, Green J, Berrington de González VA, Appleby P, Peto J, Plummer M, Franceschi S, Beral V. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003; 361: 115967.
  • 63
    Pater MM, Hughes GA, Hyslop DE, Nakshatri H, Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature 1988; 335: 8325.
  • 64
    Petrucco OM, Seamark RF, Holmes K, Forbes IJ, Symons RG. Changes in lymphocyte function during pregnancy. Br J Obstet Gynaecol 1976; 83: 24550.
  • 65
    Bocciolone L, La Vecchia C, Levi F, Lucchini F, Franceschi S. Trends in uterine cancer mortality in the Americas, 1955–1988. Gynecol Oncol 1993; 51: 33544.
  • 66
    ParkinDM, MuirC, WhelanS, GaoYT, FerleyJ, PowellJ, eds. Cancer incidence in five continents, vol. VI. IARC Scientific Publications No. 120. IARC Press: Lyon, 1992.